Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab-Reference-Cited by-同舟云学术

Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab

Published:2020-01-25 Issue:4 Volume:92 Page:3161-3170
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Yu Chuanfei¹,Zhang Feng¹,Xu Gangling¹,Wu Gang¹,Wang Wenbo¹,Liu Chunyu¹,Fu Zhihao¹,Li Meng¹,Guo Sha¹,Yu Xiaojuan¹,Wang Lan¹^ORCID

Affiliation:

1. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, No. 29, Huatuo Road, Daxing District, Beijing 102629, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Institutes for Food and Drug Control

Publisher

American Chemical Society (ACS)

Subject

Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.9b04871

Reference27 articles.

1. Avastin (bevacizumab) full prescribing information. Genentech, Inc.: South San Francisco, CA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125085s323lbl.pdf (accessed January 17, 2020).

2. Shanghai eye treatment outbreak: bevacizumab therapy for AMD in China

3. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

4. Vascular Endothelial Growth Factor: Basic Science and Clinical Progress

5. U.S. Food and Drug Administration Briefing Document. Background information for the Oncologic Drugs Advisory Committee: Biologics License Application for ABP 215. Submitted July 13, 2017, by Amgen, Inc.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics;J PHARM ANAL;2024

2. Basic Regulatory Science Behind Drug Substance and Drug Product Specifications of Monoclonal Antibodies and Other Protein Therapeutics;Journal of Pharmaceutical Analysis;2023-12

3. A novel filter-assisted protein precipitation (FAPP) based sample pre-treatment method for LC-MS peptide mapping for biosimilar characterization;Journal of Pharmaceutical and Biomedical Analysis;2023-09

4. Assessment of structural and functional similarity of biosimilar products: Bevacizumab as a case study;Journal of Chromatography B;2023-09

5. Comparative stability study and aggregate analysis of Bevacizumab marketed formulations using advanced analytical techniques;Heliyon;2023-09